Related Experiment Video
Updated: Oct 7, 2025

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
Astrocyte in prion disease: a double-edged sword.
Waqas Tahir1, Simrika Thapa1, Hermann M Schatzl1
1Department of Comparative Biology & Experimental Medicine, Faculty of Veterinary Medicine; Calgary Prion Research Unit; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Prion diseases involve misfolded proteins damaging the central nervous system. Astrocytes play a complex role in this neurodegeneration, with new models aiding research into therapeutic targets.
Area of Science:
- Neuroscience
- Cell Biology
- Infectious Diseases
Background:
- Prion diseases are fatal neurodegenerative disorders caused by misfolded prion proteins (PrPSc).
- Astrocytes, once considered secondary players, are now recognized for their complex role in prion pathogenesis.
- Understanding astrocyte involvement is crucial for developing effective prion disease therapies.
Purpose of the Study:
- To review the multifaceted role of astrocytes in prion disease pathogenesis.
- To discuss current experimental models and their limitations.
- To outline future strategies for investigating astrocyte contributions to prion diseases.
Main Methods:
- Review of existing literature on prion diseases and astrocyte biology.
- Discussion of a newly established murine astrocyte cell line persistently infected with prions.
- Analysis of challenges in modeling prion-infected astrocytes.
Main Results:
- Astrocytes can propagate prions and exhibit differential responses based on prion strains.
- Reactive astrocyte subpopulations (neurotrophic/neurotoxic) are identified in prion-infected brains.
- Existing in vitro models are insufficient for fully elucidating astrocyte roles.
Conclusions:
- Astrocytes significantly contribute to prion disease pathogenesis through complex interactions.
- Development of advanced in vitro and in vivo models is essential for further research.
- Targeting astrocyte-specific pathways may offer novel therapeutic strategies for prion diseases.
Related Concept Videos
Glial Cells
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
The Blood-brain Barrier
Nervous Tissue: Glial Cells
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...

